Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Low-Dose Danazol for the Treatment of Telomere Related Diseases — Stella

Home/Telomere Disease/Low-Dose Danazol for the Treatment of Telomere Related Diseases

View on ClinicalTrials.gov

Recruiting

Back to Telomere Disease trials

Low-Dose Danazol for the Treatment of Telomere Related Diseases

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

National Institutes of Health Clinical Center, Bethesda, Maryland

Key details

Phase

Safety & dosing

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~40 participants

Started

February 2018

Primary completion

April 2026

Age range

3 Years – 99 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.